CN113846060A - Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells - Google Patents

Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells Download PDF

Info

Publication number
CN113846060A
CN113846060A CN202111271780.XA CN202111271780A CN113846060A CN 113846060 A CN113846060 A CN 113846060A CN 202111271780 A CN202111271780 A CN 202111271780A CN 113846060 A CN113846060 A CN 113846060A
Authority
CN
China
Prior art keywords
nano
differentiation
double hydroxide
layered double
embryonic stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111271780.XA
Other languages
Chinese (zh)
Other versions
CN113846060B (en
Inventor
朱融融
程黎明
王照洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Tongji Hospital
Original Assignee
Shanghai Tongji Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Tongji Hospital filed Critical Shanghai Tongji Hospital
Priority to CN202111271780.XA priority Critical patent/CN113846060B/en
Publication of CN113846060A publication Critical patent/CN113846060A/en
Application granted granted Critical
Publication of CN113846060B publication Critical patent/CN113846060B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14Calcium; Ca chelators; Calcitonin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/16Magnesium; Mg chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/22Zinc; Zn chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to an application of a nano material in promoting differentiation of embryonic stem cells to neural precursor cells. The method firstly adopts a coprecipitation method to synthesize the nano-layered double hydroxide consisting of different metal ions at normal temperature, a cell survival rate detection experiment proves that the nano-layered double hydroxide has low cytotoxicity on the embryonic stem cells, and by detecting the expression of a neural precursor cell marker gene or protein, the nano-layered double hydroxide added into a system for inducing the embryonic stem cells to differentiate into the neural precursor cells is found to remarkably promote the differentiation, and the adding time and concentration of the nano-layered double hydroxide are further optimized, so that the induced differentiation effect is remarkably improved. The invention provides a new strategy for promoting the differentiation of embryonic stem cells to neural precursor cells and creates conditions for treating related diseases of the nervous system.

Description

Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells
Technical Field
The invention relates to induced differentiation of stem cells, in particular to application of a nano material in promoting differentiation of embryonic stem cells to neural precursor cells.
Background
Stem cell transplantation brings new hopes for the treatment of central nervous system diseases, and the regulation and mechanism analysis of stem cell fate are leading research fronts and hot spots in the field. Embryonic Stem Cells (ESCs) with totipotency of differentiation can be differentiated into specific nerve cell types under a proper external signal induction condition, including Neural Precursor Cells (NPCs), dopaminergic neurons, motor neurons, oligodendrocyte precursor cells and the like, and provide a series of solutions for treatment after nerve injury. Among them, NPCs are not only capable of self-renewal and differentiation into all types of nerve cells, but also capable of migration and integration into damaged sites of the central nervous system, and thus are ideal therapeutic means for nervous system-related diseases. Therefore, finding a new method for regulating differentiation of ESCs into NPCs and revealing the mechanism of ESCs have important scientific significance.
The prior art discloses some differentiation methods of ESCs to NPCs, for example, patent document CN107254442A discloses a method for differentiating neural precursor cells from embryonic stem cells, which is characterized in that the embryonic stem cells are cultured in vitro in the form of colonies, and peripheral cells are more easily differentiated due to the compact cells in the middle of the colonies and strong interaction among the cells; journal paper (plum, chenhong wei, huixing, etc. directed differentiation of human embryonic stem cells into neural precursor cells [ J ] zoology research, 2007,28 (3)) discloses inducing the directional differentiation of human embryonic stem cells cultured in a homologous feeder layer under a serum-free condition by adopting a single-layer adherent differentiation method to obtain a high proportion of neural precursor cells; journal papers (huzhixing, gunny, liangming. hepatocyte growth factor promotes differentiation of human embryonic stem cells into neural precursor cells [ J ]. journal of chinese pathophysiology, 2010,26(4) ], disclose that a serum-free neural differentiation system containing Hepatocyte Growth Factor (HGF) and G5 can effectively induce neural differentiation of hESCs.
Since the size of the nano material is similar to that of biological molecules, the nano material is easy to interact with DNA or protein in organs, tissues or cells, and the research of regulating and controlling the fate of ESCs through the physicochemical properties of the nano material is an important research direction in the field. In recent years, more and more studies have been conducted to control the neural differentiation process of ESCs using nanomaterials with stable biochemical properties. The nanomaterial can induce differentiation of ESCs into motor neurons, dopaminergic neurons, and glial cells. However, no report related to the regulation of differentiation from ESCs to NPCs by nanomaterials is available at present.
Disclosure of Invention
The invention aims to provide a new application of nano-layered double hydroxide aiming at the defects in the prior art.
It is still another object of the present invention to provide a method for promoting differentiation of embryonic stem cells into neural precursor cells.
In order to achieve the first purpose, the invention adopts the technical scheme that:
the application of the nano layered double hydroxide in promoting the differentiation of embryonic stem cells to neural precursor cells.
As a preferred embodiment of the invention, the nano-layered double hydroxide has divalent metal cations selected from Mg2+、Zn2+And Ca2+
As another preferred example of the present invention, the nano-layered double hydroxide has a trivalent metal cation selected from Al3+And Fe3+
As another preferred example of the present invention, the nano-layered double hydroxide has an interlayer anion selected from Cl-、NO3 -And SO4 2-
In another preferred embodiment of the present invention, the molar ratio of the divalent metal ions to the trivalent metal ions of the nano-layered double hydroxide is (0.1-5): 1.
As another preferable example of the present invention, the nano-layered double hydroxide has a general formula of [ M2+ (1-x)M3+ x(OH)2]x+[An-]x/n·zH2O, wherein M2+Is a divalent metal cation, M3+Is a trivalent metal cation, An-Is an anion with the valence of n between layers, x is the molar ratio of trivalent cations to all cations, and z is the number of crystal water between each nano-layered double hydroxide molecule.
In order to achieve the second object, the invention adopts the technical scheme that:
a method for promoting differentiation of embryonic stem cells into neural precursor cells comprises the step of adding a nano layered double hydroxide into a system for differentiation of embryonic stem cells into neural precursor cells.
As a preferred example of the present invention, the nano-layered double hydroxide is added on days 3 to 5 of the induced differentiation culture.
As another preferable example of the present invention, the concentration of the nano-layered double hydroxide in the differentiation system is 1 to 40. mu.g/mL.
More preferably, the concentration of the nano-layered double hydroxide in the differentiation system is 10 μ g/mL.
The invention has the advantages that:
1. the method specifically induces the differentiation of the ESCs to the NPCs by adopting the nano-layered double hydroxide for the first time, defines the new function of the nano-layered double hydroxide in the regulation and control of the fate of the ESCs, and provides a strategy for optimizing a differentiation system of the ESCs to the NPCs.
2. According to the invention, the nanolayered double hydroxide and the ESCs are co-cultured, materials are added into a differentiation system of the ESCs according to concentration gradients and different time windows respectively, and the expression levels of the corresponding NPCs marker genes and proteins are detected, so that the appropriate concentration and the key time window for promoting the NPCs differentiation by the nanolayered double hydroxide are found, and the effect of induced differentiation is obviously improved.
3. The invention adopts the immunoblotting method to determine the effect of the nano-layered material in promoting the differentiation of the ESCs to the NPCs, and provides a new strategy for optimizing the neural differentiation system of the ESCs.
Drawings
FIG. 1: characterization of the nanomaterial LDH and effect on the cell proliferative capacity of mESCs. (A) TEM detects the structure of two LDHs; (B) detecting the Zeta potential of the surface of the material; (C) CCK8 measures cell viability at different concentrations of LDH-treated mESCs 24h and 48 h.
FIG. 2: qPCR detects the influence on the expression level of NPCs marker genes Sox1, Pax6, N-cadherin and Map2 after MgFe-LDH and MgAl-LDH materials are added in the differentiation of ESCs to NPCs.
FIG. 3: screening the optimal time window for MgFe-LDH materials to promote the differentiation of mESCs to NPCs. (A) The qPCR detects the expression level of NPCs marker genes Sox1, Pax6, N-cadherin and Map2 after MgFe-LDH is added on the 1 st to 5 th days during the differentiation of ESCs to NPCs; (B) immunofluorescence detects the fluorescence signals of the marker proteins Sox1, Pax6 and N-cadherin.
FIG. 4: and (3) screening the optimal concentration of the MgFe-LDH material for promoting differentiation of ESCs to NPC. (A) qPCR detects the expression level of NPCs marker gene after materials with different concentrations are added in the 5 th day of the differentiation process of NPCs; (B) detecting the expression of the NPCs marker protein by Western blot; (C) and (5) carrying out quantitative statistics on the Western blot.
Detailed Description
The following detailed description of the present invention will be made with reference to the accompanying drawings.
Mouse Embryonic Stem Cells (ESCs) are derived from a blastocyst inner cell mass, are pluripotent stem cells with self-renewal and multidirectional differentiation potential, are induced into Neural Precursor Cells (NPCs) and have high survival rate and plasticity in nerve transplantation, and can reduce the risk of teratoma formation. Therefore, a complete set of induction culture system for NPCs differentiation can provide a foundation for future clinical cell transplantation treatment.
In the following examples, DMEM, fetal bovine serum, GMEM, serum analogs (KOSR), non-essential amino acids, glutamine and diabody, which are used as essential components of cell culture media for maintaining normal cell growth, are commercially available products from Gibco, USA, and other non-self-made reagents and materials are commercially available.
Example 1
1. Two LDH materials with different metal elements are successfully prepared, and characterization and biocompatibility detection are carried out on the LDH materials
(1) Preparation of magnesium-aluminum-magnesium-iron LDH (layered double hydroxide) nano material
Step one, preparing 60mL salt solution by using 6mmol of magnesium nitrate and 2mmol of aluminum nitrate or 2mmol of ferric nitrate, wherein Mg2+With Al3+Or Fe3+The molar ratio therebetween was 3: 1.
Step two, CO removal2ddH of2A0.016M NaOH solution (40 mL) was prepared using O (double distilled water) as a solvent.
Step three, continuously administering N2Meanwhile, the mixed salt prepared in the step one60mL of the solution was added to 40mL of 0.016M NaOH solution obtained in step two under vigorous stirring (400 rpm) to obtain a first suspension.
And step four, transferring the first suspension to a hydrothermal synthesis kettle, and heating for 16h at 100 ℃ to obtain a second suspension.
Step five, centrifuging 20000g for 15min to collect the product and removing CO2After washing twice with the double distilled water, the colloidal material was stored in a refrigerator at 4 ℃.
And step six, drying the second suspension in a vacuum drying oven to obtain magnesium-aluminum LDH (MgAl-LDH) or magnesium-iron LDH (MgFe-LDH).
And (3) detecting the structure of the material by using a Transmission Electron Microscope (TEM), preparing two LDHs into a suspension of 0.1mg/mL, and ultrasonically dispersing for 30min to enable the sample to be a uniform solution, wherein FIG. 1A is a transmission electron microscope morphology image of the two LDHs. As shown in FIG. 1A, MgAl-LDH and MgFe-LDH both have hexagonal layered structures, are distributed uniformly, and have particle sizes of about 80-120nm (FIG. 1A).
(2) Surface potential determination of nano LDH
The two LDHs are prepared into 1mg/mL suspension, the sample is made into a uniform solution by ultrasonic dispersion for 30min, particle size detection and surface Zeta potential detection are carried out by using a particle size analyzer, and the detection result is shown in figure 1B. FIG. 1B is the surface potential of both LDHs at a concentration of 0.5mg/mL, indicating that the surface potential of MgAl-LDH is about 24.4mV and the surface potential of MgFe-LDH is about 13.4mV, indicating that both LDH materials in this example have Zeta potentials that are positive, are stable, and facilitate contact with negatively charged cell membranes and entry into the cells.
(3) Cell viability assay for ESCs following Nano-LDH treatment
Step one, culturing the mouse embryonic stem cell ESCs. ESCs were plated on 96-well plates at 8000 plates/well in medium at 37 ℃ with 5% CO2Culturing for 24h under the condition for subsequent treatment of the medicine or the material. The ESCs culture medium comprises the following raw materials: DMEM; FBS; (ii) glutamine; double antibody. In this experiment, the incubation time was 24 h.
And step two, preparing solutions with five concentrations, wherein the concentrations are 2.5 mu g/mL, 5 mu g/mL, 10 mu g/mL, 20 mu g/mL and 40 mu g/mL in sequence.
And step three, discarding the supernatant of the ESCs cells cultured in the step one, adding LDH solutions with different concentrations prepared in the step two into each hole, culturing for 24 hours, adding 10 mu L of CCK-8 solution with the concentration of 5mg/mL into each hole, placing for 2 hours in a dark place, vibrating for 10s in the dark place, and measuring the OD (optical density) value at the position of 455nm wavelength by using a microplate reader, wherein the detection result is shown in figure 1C. The cell proliferation capacity of the mESCs is detected after the two LDH materials are respectively treated for 7 days according to concentration gradients of 2.5 mu g/mL, 5 mu g/mL, 10 mu g/mL, 20 mu g/mL and 40 mu g/mL, and the result shows that the cell proliferation capacity is not influenced.
2. MgFe-LDH can better promote mESCs to differentiate into NPCs than MgAl-LDH material
Step one, culturing the mouse embryonic stem cell ESCs. ESCs were plated on 6cm suspension culture dishes at a plating density of 2X 105Cell/well, cultured in Neural Precursor Cells (NPCs) medium at 37 deg.C in 5% CO2Performing differentiation culture for 1-5 days under the condition for subsequent treatment of medicine or material. The NPCs culture medium comprises the following raw materials: GMEM; 8% KOSR; 1% glutamine; 1% double antibody. The media components are commercially available from Gibco.
And step two, respectively preparing MgFe-LDH and MgAl-LDH solutions with the concentrations of 2.5 mug/mL, 5 mug/mL and 10 mug/mL, adding two LDH materials with different concentrations for treating for 48 hours on the 5 th day of differentiation from the ESCs to the NPCs, collecting cells at each time point, cracking by Trizol, extracting total RNA, carrying out reverse transcription by using a cDNA reverse transcription kit to obtain cDNA, and detecting expression of NOC differentiation related genes by real-time quantitative PCR (Sox1, Pax6, N-cadherin and Map 2).
And step three, finding the NPCs marker gene expression by using qPCR detection, and finding that the NPCs treated by MgFe-LDH under various concentration conditions can better promote the expression of NPCs marker genes Sox1, Pax6, N-cadherin and Map2 compared with a control group and an MgAl-LDH group by using the result of figure 2, so that the material is adopted in subsequent experiments.
3. Optimum time point for MgFe-LDH nano material to promote differentiation of ESCs to NPCs
Step one, inoculating ESCs on a 6cm suspension culture dish, and paving the dish at a density of 2 multiplied by 105And/well, considering that the differentiation of NPCs reaches higher maturity substantially at day 5, we added 10. mu.g/mL of MgFe-LDH material to the differentiation of ESCs to NPCs at days 1-5, changed the culture broth every 3 days and harvested the cells to examine the differentiation efficiency of NPCs at day 7 by qPCR, respectively, FIG. 3A is the effect on the differentiation marker genes Sox1, Pax6, N-cadherin and Map2 of NPCs after the addition of MgFe-LDH material at days 1, 2, 3, 4 and 5, respectively, and the results show that LDH can promote the expression of Sox1, Pax6, N-cadherin and Map2 to the differentiation thereof after the addition of the early (days 1-2) and late (days 3-5) stages of NPCs differentiation.
And step two, adding MgFe-LDH materials on the 1 st day, the 3 rd day and the 5 th day of the NPCs differentiation, collecting cells of each group on the 7 th day of the differentiation, and detecting differentiation markers of the NPCs after treatment of each group by immunofluorescence staining, wherein the differentiation markers comprise Sox1, Pax6 and N-cadherin. Fixing the cells with 4% paraformaldehyde for 10min, washing with PBS for three times, permeating with 0.25% Triton X-100 (polyethylene glycol octyl phenyl ether) for 10min, then blocking with 5% goat serum for 1h to inhibit nonspecific antibody binding, incubating overnight at 4 ℃ with Sox1, Pax6 and N-cadherin primary antibody (diluted 1: 500), washing with PBS for three times, incubating at room temperature with fluorescent secondary antibody (diluted 1: 200) for 1h, washing with PBS for three times, incubating DAPI (37 ℃, 15min) for cell nucleus staining, and observing staining condition with a fluorescence confocal microscope. The antibodies used therein were all commercially available from Abcam. The results shown in FIG. 3B show that the amounts of Sox1, Pax6 and N-cadherin in NPCs after addition of the materials on day 1 were lower than those of the control group (treated without addition of the materials), that the fluorescence intensities of Pax6 and N-cadherin after addition of the materials on day 3 were higher than those of the control group, and that the protein fluorescence intensities of Pax6 and N-cadherin after addition of the materials on day 5 were the highest. This indicates that the optimal time point for MgFe-LDH nanomaterials to promote differentiation of ESCs into NPCs was day 5 of differentiation.
4. Optimal concentration screening of nano LDH material for promoting differentiation of ESCs to NPC
Step one, adding 2.5, 5, 10, 20 and 40 mu g/mL of MgFe-LDH materials respectively on the 5 th day of the differentiation process of NPCs, and detecting the differentiation efficiency of the NPCs after MgFe-LDH treatment under different concentration conditions by utilizing qPCR (figure 4A) and WB (figure 4B) on the 7 th day, wherein the qPCR results in figure 4A show that under the concentration condition of 10 mu g/mL, the expression levels of marker genes Sox1, Pax6, N-cadherin and Map2 corresponding to the NPCs are higher than that under the treatment under other concentration conditions;
step two, respectively adding 2.5, 5, 10, 20 and 40 mu g/mL MgFe-LDH materials in the NPCs differentiation process on the 5 th day, detecting the influence on the NPCs marker proteins after the MgFe-LDH materials are treated under different concentration conditions by using a protein immunoprecipitation technology (WB) on the 7 th day, quantitatively detecting the total proteins extracted from each group of cells, loading the total proteins to the sample according to the same protein amount, performing polyacrylamide gel electrophoresis, performing membrane transfer, sealing and incubation corresponding to a primary antibody and a secondary antibody on the gel after the electrophoresis is finished, exposing corresponding protein bands by using ECL luminescence liquid, and comparing the expressions of the NPCs marker proteins Sox dh 1, Pax6 and N-calcin after each group of treatment. The WB level test results in FIG. 4B also demonstrated that the protein expression levels of N-cadherin and Pax6 were higher at a concentration of 10. mu.g/mL than in the other groups under the condition of consistent expression of the internal reference protein, and the quantitative statistics in FIG. 4C also demonstrated that the optimal concentration condition of MgFe-LDH for promoting the differentiation of mESCs into NPCs was 10. mu.g/mL.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and additions can be made without departing from the method of the present invention, and these modifications and additions should also be regarded as the protection scope of the present invention.

Claims (10)

1. The application of the nano layered double hydroxide in promoting the differentiation of embryonic stem cells to neural precursor cells.
2. Use according to claim 1, characterized in that the nano-layered double hydroxide has a divalent metal cation selected from Mg2+、Zn2+And Ca2+
3. Use according to claim 1, characterized in that the nano-layered double hydroxide has its trivalent metal cation selected from Al3+And Fe3+
4. Use according to claim 1, characterized in that the nano-layered double hydroxide has interlayer anions selected from the group consisting of Cl-、NO3 -And SO4 2-
5. The use according to claim 1, wherein the nano-layered double hydroxide has a molar ratio of divalent metal ions to trivalent metal ions of (0.1-5): 1.
6. Use according to claim 1, characterized in that the nano-layered double hydroxide has the general formula [ M [ ]2+ (1-x)M3 + x(OH)2]x+[An-]x/n·zH2O, wherein M2+Is a divalent metal cation, M3+Is a trivalent metal cation, An-Is an anion with the valence of n between layers, x is the molar ratio of trivalent cations to all cations, and z is the number of crystal water between each nano-layered double hydroxide molecule.
7. A method for promoting differentiation of embryonic stem cells into neural precursor cells, which comprises the step of adding a nano-layered double hydroxide into a system for differentiation of embryonic stem cells into neural precursor cells.
8. The method of claim 7, wherein the nano-layered double hydroxide is added on days 3-5 of the induced differentiation culture.
9. The method according to claim 7, wherein the concentration of the nano-layered double hydroxide in the differentiation system is 1 to 40 μ g/mL.
10. The method according to claim 9, wherein the concentration of the nano-layered double hydroxide in the differentiation system is 10 μ g/mL.
CN202111271780.XA 2021-10-29 2021-10-29 Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells Active CN113846060B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111271780.XA CN113846060B (en) 2021-10-29 2021-10-29 Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111271780.XA CN113846060B (en) 2021-10-29 2021-10-29 Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells

Publications (2)

Publication Number Publication Date
CN113846060A true CN113846060A (en) 2021-12-28
CN113846060B CN113846060B (en) 2024-04-19

Family

ID=78983523

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111271780.XA Active CN113846060B (en) 2021-10-29 2021-10-29 Application of nanomaterial in promoting differentiation of embryonic stem cells to neural precursor cells

Country Status (1)

Country Link
CN (1) CN113846060B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114908045A (en) * 2022-05-16 2022-08-16 同济大学 Application of nano layered double hydroxide/graphene quantum dot composite material in osteogenic differentiation and preparation thereof
CN114934012A (en) * 2022-05-16 2022-08-23 同济大学 Application of nano layered double hydroxide in cartilage regeneration and preparation thereof
CN115364117A (en) * 2022-07-28 2022-11-22 同济大学 Application of nano-layered double hydroxide in inflammatory bowel disease
CN115364117B (en) * 2022-07-28 2024-06-04 同济大学 Application of nano layered double hydroxide in inflammatory bowel disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2510699A (en) * 1997-12-19 1999-07-12 Oliver Brustle Neural precursor cells, method for the production and use thereof in neural defect therapy
CN103966160A (en) * 2014-04-11 2014-08-06 同济大学 Application of inorganic nano-material layered double hydroxides (LDHs) in mouse embryonic stem cell culture
CN108339151A (en) * 2018-02-08 2018-07-31 上海市同济医院 A kind of nano layered double hydroxides-multiple-factor combined system for promoting nerve regneration to repair spinal cord injury
CN111808798A (en) * 2020-09-03 2020-10-23 朗姿赛尔生物科技(广州)有限公司 Culture medium for promoting stem cell expansion

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2510699A (en) * 1997-12-19 1999-07-12 Oliver Brustle Neural precursor cells, method for the production and use thereof in neural defect therapy
US20080213888A1 (en) * 1997-12-19 2008-09-04 Oliver Brustle Neural precursor cells, method for the production and use thereof in neural defect therapy
CN103966160A (en) * 2014-04-11 2014-08-06 同济大学 Application of inorganic nano-material layered double hydroxides (LDHs) in mouse embryonic stem cell culture
CN108339151A (en) * 2018-02-08 2018-07-31 上海市同济医院 A kind of nano layered double hydroxides-multiple-factor combined system for promoting nerve regneration to repair spinal cord injury
CN111808798A (en) * 2020-09-03 2020-10-23 朗姿赛尔生物科技(广州)有限公司 Culture medium for promoting stem cell expansion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YOUJUN WU 等: "Size-dependent effects of layered double hydroxide nanoparticles on cellular functions of mouse embryonic stem cells", NANOMEDICINE (LOND.), vol. 10, no. 23, 26 November 2015 (2015-11-26), pages 3469 *
孟凡刚 等: "胚胎干细胞向神经细胞分化及其在神经科学领域中的应用现状及前景", 国外医学神经病学神经外科学分册, vol. 31, no. 2, 30 April 2004 (2004-04-30), pages 190 - 193 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114908045A (en) * 2022-05-16 2022-08-16 同济大学 Application of nano layered double hydroxide/graphene quantum dot composite material in osteogenic differentiation and preparation thereof
CN114934012A (en) * 2022-05-16 2022-08-23 同济大学 Application of nano layered double hydroxide in cartilage regeneration and preparation thereof
CN114934012B (en) * 2022-05-16 2023-11-10 同济大学 Application of nano layered double hydroxide in cartilage regeneration and preparation thereof
WO2023221988A1 (en) * 2022-05-16 2023-11-23 同济大学 Use of nano layered double hydroxides in cartilage regeneration and method for preparing same
CN115364117A (en) * 2022-07-28 2022-11-22 同济大学 Application of nano-layered double hydroxide in inflammatory bowel disease
CN115364117B (en) * 2022-07-28 2024-06-04 同济大学 Application of nano layered double hydroxide in inflammatory bowel disease

Also Published As

Publication number Publication date
CN113846060B (en) 2024-04-19

Similar Documents

Publication Publication Date Title
JP6257520B2 (en) Automated system for generating induced pluripotent stem cells or differentiated cells
CN113846060A (en) Application of nano material in promoting differentiation of embryonic stem cells to neural precursor cells
Dai et al. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach
CN106399231B (en) Application of nano graphene oxide in promoting culture and self-renewal of mouse embryonic stem cells
JP6889107B2 (en) Nervous system cells expressing adenovirus E4ORF1, and methods for producing and using them.
CN108504625B (en) Mouse fibroblast and application thereof
CN106350521B (en) A kind of preparation method of the patient-specific motor neuron of ALS
WO2018143312A1 (en) Differentiation control method for pluripotent stem cells
Wang et al. The neural stem cell properties of PKD2L1+ cerebrospinal fluid-contacting neurons in vitro
CN111254108B (en) Silk protein hydrogel and preparation method and application thereof
CN114207111A (en) Method for preparing skin-derived pluripotent precursor cells
Tang et al. The combination of dextran sulphate and polyvinyl alcohol prevents excess aggregation and promotes proliferation of pluripotent stem cells in suspension culture
CN114657184B (en) Multivalent aptamer functionalized DNA nanostructure probe and preparation method and application thereof
WO2019163802A1 (en) Method for evaluating embryoid body
CN107964533B (en) Molybdenum disulfide used for stem cell proliferation and/or differentiation and substrate for stem cell proliferation and/or differentiation, preparation method and application
WO2022188395A1 (en) Method for culturing pluripotent stem cells
CN111592585A (en) Application of UL16 protein in preparation of drugs for promoting cell mitochondrial function
CN113801843B (en) Method for enhancing human urine-derived stem cell stem property
EP2845899B1 (en) Method for preparing dopaminergic neuron-like cell cluster
JP2010004796A (en) Differentiation inhibitor, differentiation inhibitory base material, and differentiation inhibiting method and use of the method
Jasty et al. Profiling of DNA and histone methylation reveals epigenetic-based regulation of gene expression during retinal differentiation of stem/progenitor cells isolated from the ciliary pigment epithelium of human cadaveric eyes
CN115885037A (en) Midbrain organoid, high-speed large-scale production method thereof, method for screening neurotoxic substance and method for screening dopaminergic neuron-related disease drug using the same
WO2019225672A1 (en) Method for inducing conjunctival cells derived from pluripotent stem cells
CN111643522B (en) Application of nano-hydroxyapatite in preparation of drugs for preventing or treating basal cell carcinoma
KR20190130394A (en) A composition for stimulating differentiation of stem cell comprising multi-layer graphene film and culture broth of progenitor cell

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant